HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 547 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2023. The put-call ratio across all filers is 3.18 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,558,795 | -41.9% | 255,500 | -48.4% | 0.79% | -34.6% |
| Q2 2023 | $50,910,750 | -37.0% | 495,000 | -33.1% | 1.21% | -37.2% |
| Q1 2023 | $80,774,514 | -4.0% | 740,100 | +0.1% | 1.93% | -4.9% |
| Q4 2022 | $84,177,860 | +87.1% | 739,700 | +1.7% | 2.03% | +74.4% |
| Q3 2022 | $44,994,000 | -24.4% | 727,000 | -2.5% | 1.16% | -32.9% |
| Q2 2022 | $59,501,000 | -24.2% | 746,000 | 0.0% | 1.73% | -12.3% |
| Q1 2022 | $78,487,000 | -2.4% | 746,000 | 0.0% | 1.98% | +6.4% |
| Q4 2021 | $80,389,000 | +4.5% | 746,000 | +6.3% | 1.86% | +14.8% |
| Q3 2021 | $76,897,000 | +31.4% | 702,000 | +12.3% | 1.62% | +39.8% |
| Q2 2021 | $58,525,000 | +1.7% | 625,000 | 0.0% | 1.16% | -7.8% |
| Q1 2021 | $57,525,000 | +25.8% | 625,000 | 0.0% | 1.26% | +29.5% |
| Q4 2020 | $45,719,000 | -9.5% | 625,000 | -3.8% | 0.97% | -24.4% |
| Q3 2020 | $50,492,000 | – | 650,000 | – | 1.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |